Share on StockTwits

MedAssets (NASDAQ:MDAS) Director Terrence J. Mulligan unloaded 1,000 shares of the company’s stock on the open market in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $21.97, for a total transaction of $21,970.00. Following the transaction, the director now directly owns 927 shares in the company, valued at approximately $20,366. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

A number of research firms have recently commented on MDAS. Analysts at Raymond James reiterated an “outperform” rating on shares of MedAssets in a research note on Thursday, July 31st. They now have a $27.50 price target on the stock, up previously from $25.00. Separately, analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Finally, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00. Eleven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. MedAssets presently has a consensus rating of “Hold” and an average target price of $25.66.

MedAssets (NASDAQ:MDAS) traded down 2.55% on Thursday, hitting $21.37. The stock had a trading volume of 405,364 shares. MedAssets has a 1-year low of $19.38 and a 1-year high of $26.58. The stock’s 50-day moving average is $22.8 and its 200-day moving average is $23.17. The company has a market cap of $1.284 billion and a P/E ratio of 46.66. MedAssets also saw a large increase in short interest in July. As of July 31st, there was short interest totalling 3,868,865 shares, an increase of 62.0% from the July 15th total of 2,388,708 shares. Currently, 6.6% of the shares of the stock are short sold. Based on an average daily volume of 1,564,663 shares, the short-interest ratio is presently 2.5 days.

MedAssets (NASDAQ:MDAS) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.01. The company had revenue of $175.42 million for the quarter, compared to the consensus estimate of $175.70 million. During the same quarter in the previous year, the company posted $0.30 earnings per share. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, analysts predict that MedAssets will post $1.35 earnings per share for the current fiscal year.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.